1. Home
  2. Analysis
  3. Clonidine
  4. Hepatic-lesion

Clonidine and Hepatic lesion - a phase IV clinical study of FDA data

Summary:

Hepatic lesion is reported as a side effect among people who take Clonidine (clonidine), especially for people who are female, 60+ old, also take Aredia, and have Bone loss.

The phase IV clinical study analyzes which people have Hepatic lesion when taking Clonidine. It is created by eHealthMe based on reports of 63,883 people who have side effects when taking Clonidine from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Hepatic lesion?

Hepatic lesion is found to be associated with 670 drugs and 620 conditions by eHealthMe. Check the latest studies of Hepatic lesion.

On Jul, 19, 2026

63,883 people reported to have side effects when taking Clonidine.
Among them, 36 people (0.06%) have Hepatic lesion.

Could Clonidine cause Hepatic lesion?

Among these 36 people:

What is the gender of people who have Hepatic lesion when taking Clonidine? *

  • female: 67.65 %
  • male: 32.35 %

What is the age of people who have Hepatic lesion when taking Clonidine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.85 %
  • 40-49: 38.46 %
  • 50-59: 7.69 %
  • 60+: 50.0 %

What are other drugs people take besides Clonidine? *

  1. Aredia: 20 people, 55.56%
  2. Acetaminophen: 14 people, 38.89%
  3. Zometa: 14 people, 38.89%
  4. Lasix: 14 people, 38.89%
  5. Levaquin: 13 people, 36.11%
  6. Prilosec: 12 people, 33.33%
  7. Lisinopril: 11 people, 30.56%
  8. Lortab: 11 people, 30.56%
  9. Femara: 11 people, 30.56%
  10. Flomax: 10 people, 27.78%

What are other side effects people have besides Hepatic lesion? *

  1. Pain: 24 people, 66.67%
  2. Dyspnea (difficult or laboured breathing): 22 people, 61.11%
  3. Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 55.56%
  4. Constipation: 18 people, 50.00%
  5. Weakness: 18 people, 50.00%
  6. Metastases To Bone (cancer spreads to bone): 17 people, 47.22%
  7. Exposed Bone In Jaw: 16 people, 44.44%
  8. Injury: 16 people, 44.44%
  9. Diarrhea: 15 people, 41.67%
  10. Depression: 15 people, 41.67%

What are the existing conditions these people have? *

  1. Bone Loss: 7 people, 19.44%
  2. Metastases To Bone (cancer spreads to bone): 6 people, 16.67%
  3. Breast Cancer: 5 people, 13.89%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 13.89%
  5. Type 2 Diabetes: 4 people, 11.11%
  6. Fever: 4 people, 11.11%
  7. Headache (pain in head): 4 people, 11.11%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 11.11%
  9. Pain: 4 people, 11.11%
  10. Renal Cell Carcinoma (a kidney cancer): 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Hepatic lesion?

- Check whether Hepatic lesion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clonidine:

Hepatic lesion treatments and more:

How severe was Hepatic lesion and when was it recovered:

Expand to all the drugs that have ingredients of clonidine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic lesion:

Browse all the conditions that are associated with Hepatic lesion:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.